Pitfalls in evaluating the impact of persistent hematuria after induction therapy on kidney prognosis in anti-neutrophil cytoplasmic autoantibody –associated vasculitis

We have a keen interest in the recent article by Benichou et  al., which highlights that proteinuria and hematuria following remission induction are associated with outcomes in anti-neutrophil cytoplasmic antibody–associated vasculitis.1 This tackles an important topic, given its challenges for physicians. Notably, the authors assert that persistent hematu ria following induction therapy correlates with renal relapse but has no significant impact on renal prognosis. However, careful consideration is needed when interpreting these findings for 2 reasons.
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Letter to the Editor Source Type: research